Two groups, including one backed by China’s Fosun, have made competing offers to buy a 40% stake in London-listed NMC Health worth up to $1.9 billion, four sources familiar with the deal said.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
